Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

医学 心脏病学 内科学 心力衰竭 射血分数 分流(医疗) 随机对照试验 析因分析 心脏指数 心输出量 血流动力学
作者
Ravi B. Patel,Frank E. Silvestry,Jan Komtebedde,Scott D. Solomon,Gerd Hasenfuß,Sheldon E. Litwin,Barry A. Borlaug,Matthew J. Price,Rami Kawash,Scott L. Hummel,Donald E. Cutlip,Martin B. Leon,Dirk J. van Veldhuisen,Andreas Rieth,S. McKenzie,Heiko Bugger,Jeremy A. Mazurek,Samir R. Kapadia,Marc Vanderheyden,Bonnie Ky
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:9 (6): 507-507 被引量:8
标识
DOI:10.1001/jamacardio.2024.0520
摘要

Importance Although the results of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF II) trial were neutral overall, atrial shunt therapy demonstrated potential efficacy in responders (no latent pulmonary vascular disease and no cardiac rhythm management device). Post hoc analyses were conducted to evaluate the effect of shunt vs sham stratified by responder status. Objective To evaluate the effect of atrial shunt vs sham control on cardiac structure/function in the overall study and stratified by responder status. Design, Setting, and Participants This was a sham-controlled randomized clinical trial of an atrial shunt device in heart failure with preserved ejection fraction (HFpEF)/HF with mildly reduced EF (HFmrEF). Trial participants with evaluable echocardiography scans were recruited from 89 international medical centers. Data were analyzed from April 2023 to January 2024. Interventions Atrial shunt device or sham control. Main Outcome Measures Changes in echocardiographic measures from baseline to 1, 6, 12, and 24 months after index procedure. Results The modified intention-to-treat analysis of the REDUCE LAP-HF II trial included 621 randomized patients (median [IQR] age, 72.0 [66.0-77.0] years; 382 female [61.5%]; shunt arm, 309 [49.8%]; sham control arm, 312 [50.2%]). Through 24 months, 212 of 217 patients (98%) in the shunt arm with evaluable echocardiograms had patent shunts. In the overall trial population, the shunt reduced left ventricular (LV) end-diastolic volume (mean difference, −5.65 mL; P <.001), left atrial (LA) minimal volume (mean difference, −2.8 mL; P =.01), and improved LV systolic tissue Doppler velocity (mean difference, 0.69 cm/s; P <.001) and LA emptying fraction (mean difference, 1.88 percentage units; P =.02) compared with sham. Shunt treatment also increased right ventricular (RV; mean difference, 9.58 mL; P <.001) and right atrial (RA; mean difference, 9.71 mL; P <.001) volumes but had no effect on RV systolic function, pulmonary artery pressure, or RA pressure compared with sham. In the shunt arm, responders had smaller increases in RV end-diastolic volume (mean difference, 5.71 mL vs 15.18 mL; interaction P =.01), RV end-systolic volume (mean difference, 1.58 mL vs 7.89 mL; interaction P =.002), and RV/LV ratio (mean difference, 0.07 vs 0.20; interaction P <.001) and larger increases in transmitral A wave velocity (mean difference, 5.08 cm/s vs −1.97 cm/s; interaction P =.02) compared with nonresponders randomized to the shunt, suggesting greater ability to accommodate shunted blood through the pulmonary circulation enabling LA unloading. Conclusions and Relevance In this post hoc analysis of the REDUCE LAP-HF II trial, over 2 years of follow-up, atrial shunting led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers consistent with the shunt flow but no change in RV systolic function compared with sham. Changes in cardiac structure/function were more favorable in responders compared with nonresponders treated with the shunt, supporting the previously identified responder group hypothesis and mechanism, although further evaluation with longer follow-up is needed. Trial Registration ClinicalTrials.gov Identifier: NCT03088033
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
沈竑宇发布了新的文献求助10
1秒前
1秒前
杭问兰发布了新的文献求助10
2秒前
JW完成签到,获得积分10
3秒前
星辰大海应助Kuma采纳,获得30
3秒前
呆哈哈完成签到 ,获得积分10
4秒前
5秒前
啦啦咔嘞完成签到,获得积分10
6秒前
6秒前
我是老大应助YKH采纳,获得10
6秒前
可爱奇异果完成签到 ,获得积分10
7秒前
魔王完成签到,获得积分10
8秒前
溜达鸡关注了科研通微信公众号
8秒前
9秒前
啦啦咔嘞发布了新的文献求助10
9秒前
9秒前
9秒前
今后应助shinn采纳,获得30
9秒前
隐形曼青应助白藏采纳,获得10
10秒前
10秒前
10秒前
10秒前
gang发布了新的文献求助10
10秒前
11秒前
香蕉飞饼完成签到 ,获得积分10
11秒前
13秒前
mof发布了新的文献求助10
14秒前
金豆子发布了新的文献求助10
14秒前
大刀王五完成签到,获得积分10
15秒前
15秒前
15秒前
kinn应助Young采纳,获得10
15秒前
执着沛蓝发布了新的文献求助10
16秒前
17秒前
17秒前
科目三应助好柿豆花生采纳,获得30
17秒前
俏皮的飞烟完成签到,获得积分10
17秒前
大刀王五发布了新的文献求助10
17秒前
复杂语山发布了新的文献求助10
18秒前
18秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975375
求助须知:如何正确求助?哪些是违规求助? 3519700
关于积分的说明 11199305
捐赠科研通 3256034
什么是DOI,文献DOI怎么找? 1798049
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305